Manulife (Manufacturers Life Insurance)’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.1K | Hold |
69,252
| – | – | ﹤0.01% | 2872 |
|
2025
Q1 | $53.2K | Sell |
69,252
-793
| -1% | -$609 | ﹤0.01% | 2821 |
|
2024
Q4 | $89.3K | Hold |
70,045
| – | – | ﹤0.01% | 2844 |
|
2024
Q3 | $145K | Hold |
70,045
| – | – | ﹤0.01% | 2767 |
|
2024
Q2 | $267K | Sell |
70,045
-2,217
| -3% | -$8.45K | ﹤0.01% | 2472 |
|
2024
Q1 | $343K | Buy |
72,262
+2,097
| +3% | +$9.94K | ﹤0.01% | 2335 |
|
2023
Q4 | $300K | Hold |
70,165
| – | – | ﹤0.01% | 2412 |
|
2023
Q3 | $217K | Hold |
70,165
| – | – | ﹤0.01% | 2556 |
|
2023
Q2 | $316K | Buy |
70,165
+35,867
| +105% | +$161K | ﹤0.01% | 2323 |
|
2023
Q1 | $195K | Hold |
34,298
| – | – | ﹤0.01% | 2578 |
|
2022
Q4 | $191K | Buy |
34,298
+31
| +0.1% | +$173 | ﹤0.01% | 2593 |
|
2022
Q3 | $224K | Hold |
34,267
| – | – | ﹤0.01% | 2512 |
|
2022
Q2 | $178K | Hold |
34,267
| – | – | ﹤0.01% | 2716 |
|
2022
Q1 | $238K | Buy |
+34,267
| New | +$238K | ﹤0.01% | 2650 |
|
2021
Q2 | – | Sell |
-5,516
| Closed | -$239K | – | 3273 |
|
2021
Q1 | $239K | Buy |
5,516
+227
| +4% | +$9.84K | ﹤0.01% | 2770 |
|
2020
Q4 | $378K | Buy |
+5,289
| New | +$378K | ﹤0.01% | 2376 |
|